2026 NPPES data Ophthalmology Physician NPI 1447353024 MD
Verify on CMS →

MARK CALDERWOOD, MD

Ophthalmology Physician in HAMILTON, Montana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
520
Medicare Part D claims · 122 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MARK CALDERWOOD, MD is a Ophthalmology Physician ([object Object]) practicing in HAMILTON, Montana with a Medicare Part D prescribing footprint of 520 claims across 122 beneficiaries — 52% brand-name prescribing .

What stands out: MARK CALDERWOOD, MD filed 520 Medicare Part D claims in 2023 across HAMILTON, Montana. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MARK CALDERWOOD, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MARK CALDERWOOD, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 09/07/2006

NPI 1447353024

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

520 63% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Montana

How Ophthalmology Physician compares to other specialties among Montana providers

Montana providers

Ophthalmology Physician share within Montana

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Montana

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK CALDERWOOD, MD is a Ophthalmology Physician provider practicing in HAMILTON, Montana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1447353024. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK CALDERWOOD, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 300 N 10TH ST STE A, HAMILTON, MT, 59840, with a listed phone of (406) 363-5434. NPI 1447353024 was issued on 09/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CALDERWOOD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 520 prescription claims written by this provider, covering 122 Medicare beneficiaries and totaling roughly $112K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

300 N 10TH ST STE A
HAMILTON, MT 59840

Provider Details

NPI 1447353024
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 09/07/2006

Brand vs generic prescribing mix · Brand-heavy

MARK CALDERWOOD, MD — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 520 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

520
Total Claims
$112K
Total Drug Cost
122
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
801
Total Day Supply
21,323
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$106K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
78.5 years
Avg HCC Risk Score
1.03
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
203
Restasis
Cyclosporine
93
Timolol Maleate
55
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
53
Cyclosporine
18
Erythromycin
Erythromycin Base
16
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MARK CALDERWOOD, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MARK CALDERWOOD, MD's 520 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Montana

Other clinicians with the same primary specialty enrolled in Montana, drawn from the same CMS NPPES roster as CALDERWOOD.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK CALDERWOOD, MD's specialty?
MARK CALDERWOOD, MD specializes in Ophthalmology Physician and practices in HAMILTON, Montana. Credentials: MD.
How much does MARK CALDERWOOD, MD prescribe under Medicare Part D?
In 2023, MARK CALDERWOOD, MD wrote 520 Medicare Part D claims totaling $112K in drug costs for 122 beneficiaries.
Where is MARK CALDERWOOD, MD located?
MARK CALDERWOOD, MD is located at 300 N 10TH ST STE A, HAMILTON, MT, 59840. Phone: (406) 363-5434.
What is MARK CALDERWOOD, MD's NPI number?
MARK CALDERWOOD, MD's National Provider Identifier (NPI) is 1447353024, issued on 09/07/2006.
Does MARK CALDERWOOD, MD prescribe more brand-name or generic drugs?
MARK CALDERWOOD, MD's prescribing is 52% brand-name and 48% generic drugs by claim count, with $106K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MARK CALDERWOOD, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK CALDERWOOD, MD's most frequently prescribed drugs include Latanoprost, Restasis, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK CALDERWOOD, MD accept Medicare?
MARK CALDERWOOD, MD appears in CMS Medicare data with 520 Part D claims and 122 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK CALDERWOOD, MD's credentials?
MARK CALDERWOOD, MD's NPI is 1447353024 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology